TNXP SCHEDULE 13G/A: SEC filing
An institutional filer
Filed with the SEC on · accession 0000919574-26-005208
TNXP filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +1.7% by the first close after the filing.
Summary of the filing
An institutional filer submitted an amended Schedule 13G disclosing its beneficial ownership position in Tonix Pharmaceuticals Holding Corp. The filing indicates a change in the holder's previously reported ownership stake.
Key details
How TNXP stock reacted
Close before
$12.50
Aug 13, 2026
First close after
+1.68%
$12.71
5 trading days
-0.88%
$12.39
Since filing
-62.08%
$4.74
✦ Ask GOAX AI about this filing — what it means for TNXP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TNXP?
Click hereFrequently asked questions
What did TNXP file with the SEC on Aug 14, 2026?
TNXP filed a SCHEDULE 13G/A (SEC filing). An institutional filer submitted an amended Schedule 13G disclosing its beneficial ownership position in Tonix Pharmaceuticals Holding Corp. The filing indicates a change in the holder's previously reported ownership stake.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did TNXP stock react to this filing?
TNXP closed at $12.50 before the filing and $12.71 on Aug 14, 2026 (+1.68%). Five trading days later: $12.39 (-0.88%).
Other TNXP SEC filings
- 8-K · SEC filingOct 15, 2026
- 8-K · Regulatory actionOct 2, 2026
- 8-K · Contract winSep 22, 2026
- 8-K · Ceo changeSep 8, 2026
- 8-K · Executive departureAug 18, 2026
- 8-K · Guidance raiseAug 10, 2026
- 10-Q · SEC filingAug 10, 2026
- 8-K · Fda approvalAug 3, 2026
- 8-K · Executive departureJul 21, 2026
- 8-K · Contract winJul 13, 2026
Get alerts when TNXP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days